Fundraising FoxInCephalo Therapeutics
Schlieren, CH · 1 known investors
Find your way into InCephalo Therapeutics
Sign up to see every warm intro you have to InCephalo Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the InCephalo Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
InCephalo develops compartment-locked cytokine therapeutics that deliver localized immune activation to brain tumors while avoiding systemic exposure, with a lead asset targeting glioblastoma and other CNS diseases. The company is advancing a preclinical-to-clinical biotech program toward first-in-human trials.
Founders & leadership
JV
Johannes vom BergCSO & Co-Founder
Investors · 1
Frequently asked questions
- What does InCephalo Therapeutics do?
- InCephalo develops compartment-locked cytokine therapeutics that deliver localized immune activation to brain tumors while avoiding systemic exposure, with a lead asset targeting glioblastoma and other CNS diseases. The company is advancing a preclinical-to-clinical biotech program toward first-in-human trials.
- Who are InCephalo Therapeutics's investors?
- InCephalo Therapeutics's investors include Lifelink.
- Where is InCephalo Therapeutics headquartered?
- InCephalo Therapeutics is headquartered in Schlieren, CH.